• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911424300
Device Problem Occlusion Within Device (1423)
Patient Problems Dyspnea (1816); Myocardial Infarction (1969); Nausea (1970); Reocclusion (1985); ST Segment Elevation (2059); Thrombosis (2100); Vomiting (2144); Diaphoresis (2452); Chest Tightness/Pressure (2463)
Event Date 12/30/2015
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2016-11885.(b)(6) study.It was reported that myocardial infarction and in-stent restenosis occurred.In (b)(6) 2012, the patient presented with myocardial infarction (mi) and unstable angina and subsequently, cardiac catheterization was recommended.Two days after, index procedure was performed.Target lesion #1 was a de novo bifurcated lesion located in the mid left anterior descending (lad) artery with 99% stenosis and was 16mm long with a reference vessel diameter of 3.0mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00mmx24mm promus element¿ plus drug-eluting stent, with 0 % residual stenosis.Target lesion #2 was a de novo lesion located in the proximal left circumflex (lcx) artery with 99% stenosis and was 14mm long with a reference vessel diameter of 3.0mm.Target lesion #2 was treated with pre-dilatation and placement of a 3.00x20mm promus element¿ plus drug-eluting stent, with 0% residual stenosis.Three days after, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient presented to emergency department with the complaints of sub sternal chest pressure, nausea, vomiting, shortness of breath and diaphoresis.On the same day, 100% in-stent restenosis (isr) of study stent located in proximal lcx was attempted with aspiration thrombectomy, however a non-bsc catheter was difficult to pass into the old stent area.Then the lesion was treated with placement of 3.5x16mm promus premier drug-eluting stent.Following post dilatation, the residual stenosis was 0% and there was timi flow 3.Additionally, the100% isr of study stent located in mid lad was attempted with aspiration thrombectomy, however the non-bsc catheter was difficult to pass into the old stent area.Then the lesion was treated with placement of 3.5x16mm promus premier drug-eluting stent with 0% residual stenosis and timi flow 2.Later, intra aortic balloon pump (iabp) was inserted and pumping was performed which resulted timi flow 3.Three days after, the event was considered as resolved and the patient was discharged on the same day.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that stent thrombosis of the 3.00mmx24mm and 3.00x20mm promus element¿ plus stents occurred and not in-stent restenosis as previously reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6181818
MDR Text Key62605385
Report Number2134265-2016-11884
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/19/2013
Device Model NumberH7493911424300
Device Catalogue Number39114-2430
Device Lot Number15409717
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/13/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-